WeVote
Log In

Bill

Bill

SB 182

Psychoactive cannabinoids; prohibit sale of beverages containing psychoactive cannabinoids; criminal penalties provided

2025 Regular Session Introduced by Shay Shelnutt

Alabama bill prohibits selling psychoactive cannabinoid beverages and imposes criminal penalties to regulate uncontrolled intoxicating products.

Read for the first time and referred to the Senate Committee on Healthcare
#crimes&offenses
0
WeVote Research Nonpartisan
Bill Summary · SB 182

Legislative bill overview

SB 182 would prohibit the sale of beverages containing psychoactive cannabinoids (such as delta-8, delta-10, and HHC) in Alabama and establish criminal penalties for violations. The bill treats these substances separately from traditional cannabis, focusing specifically on beverage products containing synthetic or derived cannabinoids that produce intoxicating effects.

Why is this important

Psychoactive cannabinoids have become increasingly available in unregulated markets through loopholes in federal law, marketed as legal alternatives to cannabis in states where traditional marijuana is prohibited. This bill addresses public health concerns about youth access, product safety, and labeling standards for these largely unregulated substances, which currently lack federal oversight comparable to traditional pharmaceuticals or food additives.

Potential points of contention

  • Definitional scope: The bill's specific language on which cannabinoids qualify as "psychoactive" may need clarity, as compounds like delta-8 exist in a legal gray area federally and the definition could affect enforcement
  • Business impact: This would eliminate a growing commercial market in Alabama, affecting retailers and distributors currently selling these products legally under federal law
  • Enforcement complexity: Distinguishing between illegal psychoactive cannabinoids and legal hemp-derived products may present enforcement challenges for law enforcement without clear testing standards
  • Federalism questions: The bill operates in an area where federal regulation remains uncertain, potentially creating conflicts with evolving federal cannabis policy

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.